stockrow
Saturday 7 November 2026
Export OBX’s income statement to Excel — free account
Obsidian Therapeutics, Inc
14.02
4.42
+46.04%
Follow OBX
Alert me
Obsidian Therapeutics, Inc (OBX) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| KURA Kura Oncology, Inc. compare | n/m |
| OLMA Olema Pharmaceuticals, Inc. compare | n/m |
| DSGN Design Therapeutics, Inc. compare | n/m |
| AVBP ArriVent BioPharma, Inc. compare | n/m |
| NVCT Nuvectis Pharma, Inc. compare | n/m |
| IMMX Immix Biopharma, Inc. compare | n/m |
| GERN Geron Corporation compare | n/m |
| APMD Apnimed, Inc. compare | 0.8× |
| OBX Obsidian Therapeutics, Inc | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)